RESUMO
Tay-Sachs disease (TSD) is a fatal neurodegenerative disease caused by a deficiency of the enzyme ß-N-acetylhexosaminidase A (HexA). TSD naturally occurs in Jacob sheep is the only experimental model of TSD. TSD in sheep recapitulates neurologic features similar to juvenile onset and late onset TSD patients. Due to the paucity of human literature on pathology of TSD, a better natural history in the sheep TSD brain, which is on the same order of magnitude as a child's, is necessary for evaluating therapy and characterizing the pathological events that occur. To provide clinicians and researchers with a clearer understanding of longitudinal pathology in patients, we compare spectrum of clinical signs and brain pathology in mildly symptomatic (3-months), moderately symptomatic (6-months), or severely affected TSD sheep (humane endpoint at ~9-months of age). Increased GM2 ganglioside in the CSF of TSD sheep and a TSD specific biomarker on MRS (taurine) correlate with disease severity. Microglial activation and reactive astrocytes were observed globally on histopathology in TSD sheep with a widespread reduction in oligodendrocyte density. Myelination is reduced primarily in the forebrain illustrated by loss of white matter on MRI. GM2 and GM3 ganglioside were increased and distributed differently in various tissues. The study of TSD in the sheep model provides a natural history to shed light on the pathophysiology of TSD, which is of utmost importance due to novel therapeutics being assessed in human patients.
Assuntos
Encéfalo/fisiopatologia , Modelos Animais de Doenças , Ovinos , Doença de Tay-Sachs/fisiopatologia , Doença de Tay-Sachs/veterinária , Animais , Encéfalo/diagnóstico por imagem , Imageamento por Ressonância Magnética , Doença de Tay-Sachs/genéticaRESUMO
An 8-month-old female Saint Bernard dog was presented with gait abnormalities consistent with a left-lateralizing cervical myelopathy. Imaging revealed a large, irregular soft tissue and mineral mass at the level of C1 and C2. The lesion was successfully excised, and histopathology was performed, revealing evidence of both multiple cartilaginous exostoses and calcinosis circumscripta. To the authors' knowledge, this is the first report comparing features using magnetic resonance imaging, computed tomography, and radiography. Additionally, multiple cartilaginous exostoses have not previously been reported to occur in combination with calcinosis circumscripta.
Assuntos
Calcinose/veterinária , Doenças do Cão/diagnóstico , Exostose Múltipla Hereditária/veterinária , Animais , Calcinose/diagnóstico , Calcinose/diagnóstico por imagem , Calcinose/patologia , Doenças do Cão/diagnóstico por imagem , Doenças do Cão/patologia , Cães , Exostose Múltipla Hereditária/diagnóstico , Exostose Múltipla Hereditária/diagnóstico por imagem , Exostose Múltipla Hereditária/patologia , Feminino , Imageamento por Ressonância Magnética/veterinária , Radiografia/veterinária , Tomografia Computadorizada por Raios X/veterináriaRESUMO
Autophagy is a major clearance route for intracellular aggregate-prone proteins causing diseases such as Huntington's disease. Autophagy induction with the mTOR inhibitor rapamycin accelerates clearance of these toxic substrates. As rapamycin has nontrivial side effects, we screened FDA-approved drugs to identify new autophagy-inducing pathways. We found that L-type Ca2+ channel antagonists, the K+ATP channel opener minoxidil, and the G(i) signaling activator clonidine induce autophagy. These drugs revealed a cyclical mTOR-independent pathway regulating autophagy, in which cAMP regulates IP3 levels, influencing calpain activity, which completes the cycle by cleaving and activating G(s)alpha, which regulates cAMP levels. This pathway has numerous potential points where autophagy can be induced, and we provide proof of principle for therapeutic relevance in Huntington's disease using mammalian cell, fly and zebrafish models. Our data also suggest that insults that elevate intracytosolic Ca2+ (like excitotoxicity) inhibit autophagy, thus retarding clearance of aggregate-prone proteins.
Assuntos
Autofagia/efeitos dos fármacos , Doença de Huntington/fisiopatologia , Proteínas Quinases/fisiologia , Animais , Canais de Cálcio Tipo L/efeitos dos fármacos , Clonidina/farmacologia , AMP Cíclico/metabolismo , Humanos , Doença de Huntington/imunologia , Receptores de Imidazolinas/antagonistas & inibidores , Minoxidil/farmacologia , Transdução de Sinais , Serina-Treonina Quinases TOR , Fosfolipases Tipo C/metabolismo , Verapamil/farmacologiaRESUMO
Neurons are a diverse cell type exhibiting hugely different morphologies and neurotransmitter specifications. Their distinctive phenotypes are established during differentiation from pluripotent precursor cells. The signalling pathways that specify the lineage down which neuronal precursor cells differentiate remain to be fully elucidated. Among the many signals that impinge on the differentiation of neuronal cells, cytosolic calcium (Ca2+) has an important role. However, little is known about the nature of the Ca2+ signals involved in fate choice in neuronal precursor cells, or their sources. In this study, we show that activation of either muscarinic or platelet-derived growth factor (PDGF) receptors induces a biphasic increase in cytosolic Ca2+ that consists of release from intracellular stores followed by sustained entry across the plasma membrane. For both agonists, the prolonged Ca2+ entry occurred via a store-operated pathway that was pharmacologically indistinguishable from Ca2+ entry initiated by thapsigargin. However, muscarinic receptor-activated Ca2+ entry was inhibited by siRNA-mediated knockdown of TRPC6, whereas Ca2+ entry evoked by PDGF was not. These data provide evidence for agonist-specific activation of molecularly distinct store-operated Ca2+ entry pathways, and raise the possibility of privileged communication between these Ca2+ entry pathways and downstream processes.
Assuntos
Canais de Cálcio/efeitos dos fármacos , Cloreto de Metacolina/farmacologia , Agonistas Muscarínicos/farmacologia , Neurônios/efeitos dos fármacos , Fator de Crescimento Derivado de Plaquetas/farmacologia , Canais de Cálcio/metabolismo , Sinalização do Cálcio/efeitos dos fármacos , Células Cultivadas , Humanos , Immunoblotting , Neurônios/citologia , Neurônios/metabolismo , Fatores de TempoRESUMO
In this study, neurological complications associated with spontaneously occurring feline diabetes were comprehensively evaluated. Physical and neurological examinations, electrophysiological assessment, and biochemical and histological analysis of nerve and muscle biopsy specimens were performed in 19 diabetic cats and referenced to similar data from 28 nondiabetic cats without evidence of neuropathy. Compared to nondiabetic cats, diabetic cats exhibited a range of functional, structural, and biochemical defects that, depending on severity, manifested as striking neurological dysfunction. A broad spectrum of clinical signs was apparent with the most notable and severe impairment being a plantigrade posture when standing or walking. A sensorimotor neuropathy, characterized by conduction deficits and increased F wave and cord dorsum potential latencies, was present in both pelvic and thoracic limbs and, except in the most severely affected animals, occurred with little or no electromyographic abnormality. As for nerve structural abnormalities, Schwann cell injury was prevalent and included myelin defects, such as splitting and ballooning, and demyelination, although axonal degeneration was noted in biopsies from severely affected cats. Evidence of polyol pathway activity consisted of marked increases in nerve fructose without appreciable sorbitol accumulation. The occurrence of diabetic neuropathy in the cat, a relatively large animal with a long life span and long nerves, provides unique opportunities to study the development and treatment of this debilitating complication.
Assuntos
Doenças do Gato/fisiopatologia , Diabetes Mellitus/veterinária , Condução Nervosa/fisiologia , Animais , Doenças do Gato/patologia , Gatos , Diabetes Mellitus/patologia , Diabetes Mellitus/fisiopatologia , Feminino , Masculino , Fibras Nervosas/patologia , Fibras Nervosas/ultraestrutura , Exame Neurológico/veterinária , Células de Schwann/patologia , Células de Schwann/ultraestruturaRESUMO
Accurate diagnosis of the many causes of acute and chronic peripheral neuropathy in the dog presents a challenging prospect for any clinician. Being able to accurately localize the observed neurologic signs to the peripheral nervous system is the first challenge. Once this is accomplished, a logical series of diagnostic steps should be pursued so as to have the best chance of reaching a final etiologic diagnosis. Specific therapy can then be instituted to attempt to halt or, in some cases, reverse the peripheral nerve dysfunction.
Assuntos
Doenças do Cão/diagnóstico , Doenças do Sistema Nervoso Periférico/veterinária , Exame Físico/veterinária , Animais , Diagnóstico Diferencial , Cães , Exame Neurológico/veterinária , Doenças do Sistema Nervoso Periférico/diagnósticoRESUMO
Electrophysiologic assessment of the peripheral nervous system is an integral part of the diagnostic workup for neuromuscular disease. This article is designed to provide insight into the importance and limitations of the various testing procedures now available in veterinary electrophysiology and to provide the reader with an understanding of the theory behind each of these procedures. The article also provides a guideline for the interpretation and clinical significance of each of the available tests.
Assuntos
Doenças do Gato/fisiopatologia , Doenças do Cão/fisiopatologia , Eletrodiagnóstico/veterinária , Doenças Neuromusculares/veterinária , Animais , Gatos , Cães , Eletromiografia/veterinária , Eletrofisiologia , Doenças Neuromusculares/fisiopatologiaAssuntos
Doenças do Gato/diagnóstico , Doenças do Sistema Nervoso Central/veterinária , Ingestão de Líquidos , Hidratação/veterinária , Hipernatremia/veterinária , Concentração Osmolar , Animais , Doenças do Gato/terapia , Gatos , Doenças do Sistema Nervoso Central/complicações , Doenças do Sistema Nervoso Central/diagnóstico , Doenças do Sistema Nervoso Central/terapia , Hipernatremia/complicações , Hipernatremia/diagnóstico , Hipernatremia/terapia , Masculino , Poliúria/etiologia , Poliúria/veterinária , Sede/fisiologia , Resultado do TratamentoRESUMO
Two families of dogs (Australian cattle dogs and Shetland sheepdogs) with an inherited "spongiform leukoencephalomyelopathy" were identified, with widespread vacuolation of white matter of the brain and spinal cord. Affected dogs of both breeds developed tremors at 2-9 weeks of age followed by progressive neurological worsening with ataxia, paresis, paralysis, spasticity, and cranial nerve dysfunction. The modes of inheritance of both families were most likely maternal. The cerebrospinal fluid (CSF) analysis showed elevated ratio of 3-OH butyrate to acetoacetic acid. Mitochondrial DNA sequencing showed a G to A transition at 14,474 nt (G14474A, GenBank accession no. NC002008 ) that results in an amino acid change of valine-98 to methionine (V98M) of mitochondrial encoded cytochrome b. Western blot analysis showed increased levels of core I and core II but decreased level of cytochrome c1 of the complex III and cytochrome c oxidase of the complex IV of the respiratory chain.
Assuntos
Doença de Canavan/genética , Citocromos b/genética , Doenças do Cão/genética , Transtornos Heredodegenerativos do Sistema Nervoso/genética , Mutação de Sentido Incorreto , Ácido 3-Hidroxibutírico/líquido cefalorraquidiano , Acetoacetatos/líquido cefalorraquidiano , Animais , Western Blotting , Doença de Canavan/líquido cefalorraquidiano , Doença de Canavan/patologia , Citocromos c1/metabolismo , DNA Mitocondrial/genética , Doenças do Cão/líquido cefalorraquidiano , Doenças do Cão/patologia , Cães , Complexo III da Cadeia de Transporte de Elétrons/metabolismo , Complexo IV da Cadeia de Transporte de Elétrons/metabolismo , Feminino , Transtornos Heredodegenerativos do Sistema Nervoso/líquido cefalorraquidiano , Transtornos Heredodegenerativos do Sistema Nervoso/patologia , Masculino , Dados de Sequência Molecular , Fibras Nervosas Mielinizadas/patologia , LinhagemRESUMO
The clinical work-up, diagnosis and follow-up of an 8-year-old, female-spayed Shih Tzu with diffuse, granulomatous meningoencephalomyelitis (GME)-causing visual deficits is reported. The use of cytosine arabinoside as an alternative treatment for GME is discussed.
Assuntos
Doenças do Cão/diagnóstico , Granuloma/veterinária , Meningoencefalite/veterinária , Animais , Cegueira/etiologia , Cegueira/veterinária , Citarabina/uso terapêutico , Diagnóstico Diferencial , Doenças do Cão/diagnóstico por imagem , Doenças do Cão/tratamento farmacológico , Doenças do Cão/patologia , Cães , Feminino , Granuloma/complicações , Granuloma/diagnóstico , Imunossupressores/uso terapêutico , Meningoencefalite/complicações , Meningoencefalite/diagnóstico , Prednisona/uso terapêutico , Tomografia Computadorizada por Raios X/veterináriaRESUMO
OBJECTIVE: To evaluate the postoperative morbidity and long-term outcome of dogs after dorsal laminectomy for caudal cervical spondylomyelopathy (CCSM). STUDY DESIGN: Retrospective study. SAMPLE POPULATION: Twenty dogs with CCSM. METHODS: Medical records of dogs treated by dorsal laminectomy for CCSM at North Carolina State University and Colorado State University between 1989 and 1999 were reviewed. Information on signalment, onset, progression and duration of clinical signs, diagnostic testing, sites of dorsal laminectomy, postoperative complications, length of hospitalization, and the ambulatory status on discharge was recorded. A minimum follow-up of 7 months was required for inclusion in the study. Neurologic status was graded (0 to 5) preoperatively, 2 days after surgery, and at the time of the study (final score). Improvement or worsening of the neurologic status was assessed by comparison of different scores for each dog. Additional follow-up information was obtained by means of a detailed telephone questionnaire directed at both the owner and referring veterinarian. RESULTS: Mean duration of clinical signs before surgery was 4.9 months. At admission, 15 dogs were ambulatory and 5 were nonambulatory. Neurologic status worsened in 70% of dogs 2 days after surgery but improved in all but 1 dog over the long term. Mean time to optimal recovery was 3.6 months. Long-term follow-up ranged from 7 months to 9 years (mean +/- SD, 3.2 +/- 2.4 years). Four dogs had confirmed recurrence; 2 other dogs may have had recurrence. CONCLUSIONS: Dorsal cervical laminectomy is an effective treatment for CCSM in those dogs with dorsal compression or multiple sites of involvement. CLINICAL RELEVANCE: Although most dogs' neurologic status transiently worsened after surgery, long-term outcome and recurrence rates were comparable to those seen with other surgical techniques for CCSM.
Assuntos
Vértebras Cervicais , Doenças do Cão/mortalidade , Doenças do Cão/cirurgia , Laminectomia/veterinária , Osteofitose Vertebral/veterinária , Animais , Vértebras Cervicais/cirurgia , Colorado/epidemiologia , Cães , Feminino , Seguimentos , Masculino , Exame Neurológico/veterinária , North Carolina/epidemiologia , Complicações Pós-Operatórias/veterinária , Registros/veterinária , Recidiva , Estudos Retrospectivos , Osteofitose Vertebral/mortalidade , Osteofitose Vertebral/cirurgia , Resultado do TratamentoRESUMO
Neurons are a diverse cell type exhibiting hugely different morphologies and neurotransmitter specifications. Their distinctive phenotypes are established during differentiation from pluripotent precursor cells. The signalling pathways that specify the lineage down which neuronal precursor cells differentiate remain to be fully elucidated. Among the many signáis that impinge on the differentiation of neuronal cells, cytosolic calcium (Ca2+) has an important role. However, little is known about the nature of the Ca2+ signáis involved in fate choice in neuronal precursor cells, or their sources. In this study, we show that activation of either muscarinic or platelet-derived growth factor (PDGF) receptors induces a biphasic increase in cytosolic Ca2+ that consists of reléase from intracellular stores followed by sustained entry across the plasma membrane. For both agonists, the prolonged Ca2+ entry occurred via a store-operated pathway that was pharmacologically indistinguishable from Ca2+ entry initiated by thapsigargin. However, muscarinic receptor-activated Ca2+ entry was inhibited by siRNA-mediated knockdown of TRPC6, whereas Ca2+ entry evoked by PDGF was not. These data provide evidence for agonist-specific activation of molecularly distinct store-operated Ca2+ entry pathways, and raise the possibility of privileged communication between these Ca2+ entry pathways and downstream processes.